Last reviewed · How we verify
Allylpental (cyclopentobarbital)
Allylpental (generic name: cyclopentobarbital) is a cyclopentobarbital drug. It is currently in unknown development.
Allylpental works by enhancing the activity of a neurotransmitter in the brain, leading to sedation and relaxation.
Allylpental, also known as cyclopentobarbital, is a small molecule drug in the cyclopentobarbital class. Its mechanism of action and target are unknown, and it is not FDA-approved for any indications. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand this compound. Allylpental's development history is also unclear.
At a glance
| Generic name | cyclopentobarbital |
|---|---|
| Drug class | cyclopentobarbital |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Mechanism of action
Imagine your brain is a busy city with many different streets and intersections. Allylpental helps calm down the traffic by increasing the activity of a specific chemical messenger, or neurotransmitter, that helps slow down the pace of the city. This results in feelings of relaxation and reduced anxiety.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allylpental CI brief — competitive landscape report
- Allylpental updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Allylpental
What is Allylpental?
How does Allylpental work?
What is the generic name of Allylpental?
What drug class is Allylpental in?
What development phase is Allylpental in?
Related
- Drug class: All cyclopentobarbital drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing